Még nem toboroz
Risk-reducing Strategies, Including Fimbriectomy, in Women With a Germline Mutation Predisposing to Ovarian or Pelvic Cancer
NCT06726330· Centre Oscar Lambret· Forrás
Még nem toboroz
Comparison of Telerehabilitation and Usual Rehabilitation After Knee or Hip Surgery
NCT07902505· Centre Hospitalier de Valenciennes· Forrás
Még nem toboroz
ACetazolamide in Patients With Heart Failure, to Decrease Weight and relIEVE Symptoms.
NCT07737964· 3. fázis· University Hospital, Montpellier· Forrás
Még nem toboroz
Obinutuzumab for Systemic Lupus Erythematosus Pure Membranous Nephropathy: a Phase II Trial
NCT07721363· 2. fázis· Assistance Publique - Hôpitaux de Paris· Forrás
Még nem toboroz
OBINUSS - A trial to evaluate a new drug in systemic sclerosis: obinutuzumab.
2025-524003-68-00· 2. fázis· Assistance Publique Hopitaux De Paris· Forrás
Még nem toboroz
Testing Ivonescimab in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancers Without Liver Metastases
NCT07359456· 2. fázis· UNICANCER· Forrás
Toboroz
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
NCT07753993· 3. fázis· AstraZeneca· Forrás
Toboroz
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
NCT07621809· 3. fázis· Novartis Pharmaceuticals· Forrás
Még nem toboroz
Bosentan in the Treatment of Giant Cell Arteritis
NCT06957002· 2. fázis· Assistance Publique - Hôpitaux de Paris· Forrás
Toboroz
PROlonged Corticosteroid Treatment or N-ACetylcysteine for Severe Alcoholic Hepatitis
NCT06956482· 3. fázis· University Hospital, Lille· Forrás
Még nem toboroz
Comparison of a Strategy Based on Clinico-biological Monitoring Versus Pre-emptive Rituximab Treatment in Cases of ANCA Reappearance in Granulomatosis With Polyangiitis and Microscopic Polyangiitis.
NCT07451847· 4. fázis· Assistance Publique - Hôpitaux de Paris· Forrás
Toboroz
Obinutuzumab for Remission Induction in Patients With Relapsing PR3-ANCA Granulomatosis With Polyangiitis
NCT06940661· 2. fázis· Assistance Publique - Hôpitaux de Paris· Forrás
Toboroz
Adjuvant Chemotherapy +/- Cemiplimab and Sequential Hypofractionated Radiotherapy in Unfit or Elderly Patients With Stage III Lung Cancer
NCT06656598· 2. fázis· Intergroupe Francophone de Cancerologie Thoracique· Forrás
Toboroz
Therapeutic Effect of Hydroxychloroquine on Immunoglobulin A (IgA) Nephropathy Course QUIgAN Study
NCT06350630· 2. fázis· Centre Hospitalier Universitaire de Saint Etienne· Forrás
Toboroz
Breast Cancer and Chemobrain : Effects of Photobiomodulation on the Improvement of Perceived Cognitive Impairment
NCT06995443· Centre Hospitalier de Valenciennes· Forrás
Toboroz
Personalized Rituximab Treatment Based on Artificial Intelligence in Membranous Nephropathy (iRITUX)
NCT06341205· 3. fázis· Centre Hospitalier Universitaire de Nice· Forrás
Toboroz
An Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthritis
NCT06764693· AbbVie· Forrás
Fut, nem toboroz
Study To Assess Effectiveness and Adverse Events of Foscarbidopa/ Foslevodopa in Adult Participants With Advanced Parkinson Disease in Real Life Setting
NCT06639620· AbbVie· Forrás
Még nem toboroz
Safety and Efficacy of Apixaban Versus Warfarin in Peritoneal Dialysis Patients With Non Valvular Atrial Fibrillation: a Prospective, Randomised, Open-label, Blinded End-point Trial (APIDP2)
NCT06045858· 3. fázis· University Hospital, Caen· Forrás
Toboroz
Comparison of Landiolol versus standard of care for prevention of mortality in patients hospitalized for a septic shock with hypercontractlity: an open label prospective randomized study
2024-518251-31-00· 3. fázis· Centre Hospitalier Universitaire Amiens Picardie· Forrás
Fut, nem toboroz
Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)
NCT06564142· 3. fázis· Alpine Immune Sciences Inc, A Subsidiary of Vertex· Forrás
Fut, nem toboroz
Treatment of microstellite stable metastatic colorectal cancer presenting high immune infiltrate with chemotherapy (XELOX or FOLFOX Bevacizumab) and
immunotherapy ( Pembrolizumab)
NCT04262687· 2. fázis· Fondation Franc.Cancerologie Digestive· Forrás
Fut, nem toboroz
MorningLyte: Evaluation of the benefits of the combination of mosunetuzumab plus lenalidomide versus a treatment with anti-CD20 monoclonal antibody plus chemotherapy in subjects with previously untreated FLIPI 2-5 follicular lymphoma
2023-505436-35-00· 3. fázis· Lysarc· Forrás
Toboroz
UVB: treatment of UVeitis in Behçet’s diseases with biologic
2024-513371-41-00· 2. fázis· Assistance Publique Hopitaux De Paris· Forrás
Fut, nem toboroz
TocilizuMab discontinuAtion in GIant Cell Arteritis
2023-505515-21-00· 3. fázis· Centre Hospitalier Universitaire De Dijon· Forrás
Toboroz
A Trial to Evaluate the Efficacy of Pioglitazone to Promote Renal Tolerance in ANCA-associated Vasculitis - RENATO Trial
NCT05946564· 3. fázis· Assistance Publique - Hôpitaux de Paris· Forrás
Toboroz
Rescue of Nephrons With ALE.F02 (RENAL-F02)
NCT06047171· 2. fázis· Alentis Therapeutics AG· Forrás
Toboroz
PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 Years
NCT05387954· 3. fázis· Assistance Publique - Hôpitaux de Paris· Forrás
Toboroz
Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease
NCT05732727· 3. fázis· University Hospital, Tours· Forrás
Fut, nem toboroz
An Observational Study to Assess Change in Disease Activity and Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in Real World
NCT05669794· AbbVie· Forrás
Toboroz
ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable)
NCT04916613· 3. fázis· UNICANCER· Forrás
Toboroz
Prospective Non-interventional Study of Adult Patients With Acute Myeloid Leukemia (AML)
NCT04777916· Acute Leukemia French Association· Forrás
Toboroz
Induction Therapy for Lupus Nephritis With no Added Oral Steroids: A Trial Comparing Oral Corticosteroids Plus Mycophenolate Mofetil (MMF) Versus Obinutuzumab and MMF
NCT04702256· 3. fázis· Assistance Publique - Hôpitaux de Paris· Forrás
Fut, nem toboroz
Lorlatinib After Failure of First-line TKI in Patients With Advanced ROS1-positive NSCLC (ALBATROS)
NCT04621188· 2. fázis· Intergroupe Francophone de Cancerologie Thoracique· Forrás
Fut, nem toboroz
Atrasentan in Patients With IgA Nephropathy
NCT04573478· 3. fázis· Novartis Pharmaceuticals· Forrás
Fut, nem toboroz
Rituximab from the first episode of Minimal Change Nephrotic Syndrome for preventing relapse risk in adult patients
NCT03970577· 2. fázis· Assistance Publique Hopitaux De Paris· Forrás
Toboroz
Randomized phase 3 trial comparing FOLFOX to gemcitabine in metastatic first-line in patients with pancreatic adenocarcinoma and non-fit for FOLFIRINOX (GEMFOX)
NCT04167007· 2/3. fázis· Assistance Publique Hopitaux De Paris· Forrás
Fut, nem toboroz
Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy
NCT04083339· 3. fázis· Applied Therapeutics, Inc.· Forrás
Toboroz
Evaluate the Remission MAINtenance Using Extended Administration of Prednisone in Systemic Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis.
NCT03290456· 3. fázis· Hospices Civils de Lyon· Forrás
Fut, nem toboroz
Maintaining or Stopping Immunosuppressive Therapy in Patients With ANCA Vasculitis and End-stage Renal Disease
NCT03323476· 3. fázis· Centre Hospitalier Departemental Vendee· Forrás
Toboroz
GRAALL2014
NCT02617004· 2. fázis· Assistance Publique Hopitaux De Paris· Forrás
Fut, nem toboroz
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
NCT00005584· 3. fázis· European Organisation for Research and Treatment of Cancer - EORTC· Forrás